Literature DB >> 29100056

Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation.

Changmin Peng1, Yue Zhu2, Wanjun Zhang3, Qinchao Liao4, Yali Chen3, Xinyuan Zhao3, Qiang Guo5, Pan Shen3, Bei Zhen3, Xiaohong Qian3, Dong Yang3, Jin-San Zhang5, Dongguang Xiao4, Weijie Qin6, Huadong Pei7.   

Abstract

The Hippo pathway is crucial in organ size control and tissue homeostasis, with deregulation leading to cancer. An extracellular nutrition signal, such as glucose, regulates the Hippo pathway activation. However, the mechanisms are still not clear. Here, we found that the Hippo pathway is directly regulated by the hexosamine biosynthesis pathway (HBP) in response to metabolic nutrients. Mechanistically, the core component of Hippo pathway (YAP) is O-GlcNAcylated by O-GlcNAc transferase (OGT) at serine 109. YAP O-GlcNAcylation disrupts its interaction with upstream kinase LATS1, prevents its phosphorylation, and activates its transcriptional activity. And this activation is not dependent on AMPK. We also identified OGT as a YAP-regulated gene that forms a feedback loop. Finally, we confirmed that glucose-induced YAP O-GlcNAcylation and activation promoted tumorigenesis. Together, our data establish a molecular mechanism and functional significance of the HBP in directly linking extracellular glucose signal to the Hippo-YAP pathway and tumorigenesis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hippo; O-GlcNAcylation; OGT; YAP; pancreatic cancer

Mesh:

Substances:

Year:  2017        PMID: 29100056     DOI: 10.1016/j.molcel.2017.10.010

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  79 in total

Review 1.  YAP/TAZ Signaling and Resistance to Cancer Therapy.

Authors:  Chan D K Nguyen; Chunling Yi
Journal:  Trends Cancer       Date:  2019-03-27

2.  AMPKβ1 and AMPKβ2 define an isoform-specific gene signature in human pluripotent stem cells, differentially mediating cardiac lineage specification.

Authors:  Nicole Ziegler; Erik Bader; Alexey Epanchintsev; Daniel Margerie; Aimo Kannt; Dieter Schmoll
Journal:  J Biol Chem       Date:  2020-10-16       Impact factor: 5.157

3.  LRP6 lets Merlin go in times of nutrient scarcity.

Authors:  Kenneth Kin Lam Wong; Esther M Verheyen
Journal:  EMBO Rep       Date:  2020-08-20       Impact factor: 8.807

Review 4.  Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression.

Authors:  Andréia Vasconcelos-Dos-Santos; Rafaela Muniz de Queiroz; Bruno da Costa Rodrigues; Adriane R Todeschini; Wagner B Dias
Journal:  J Bioenerg Biomembr       Date:  2018-01-11       Impact factor: 2.945

5.  Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation.

Authors:  Jin Xiang; Chang Chen; Rui Liu; Dongmei Gou; Lei Chang; Haijun Deng; Qingzhu Gao; Wanjun Zhang; Lin Tuo; Xuanming Pan; Li Liang; Jie Xia; Luyi Huang; Ke Yao; Bohong Wang; Zeping Hu; Ailong Huang; Kai Wang; Ni Tang
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

6.  Glycolysis-Independent Glucose Metabolism Distinguishes TE from ICM Fate during Mammalian Embryogenesis.

Authors:  Fangtao Chi; Mark S Sharpley; Raghavendra Nagaraj; Shubhendu Sen Roy; Utpal Banerjee
Journal:  Dev Cell       Date:  2020-03-19       Impact factor: 12.270

Review 7.  Integration of Hippo-YAP Signaling with Metabolism.

Authors:  Consuelo Ibar; Kenneth D Irvine
Journal:  Dev Cell       Date:  2020-07-20       Impact factor: 12.270

8.  LDL receptor-related protein LRP6 senses nutrient levels and regulates Hippo signaling.

Authors:  Wonyoung Jeong; Soyoung Kim; Ukjin Lee; Zhendong A Zhong; Mikhail Savitsky; Hyeryun Kwon; Jiyoung Kim; Taebok Lee; Jin Won Cho; Bart O Williams; Vladimir L Katanaev; Eek-Hoon Jho
Journal:  EMBO Rep       Date:  2020-08-07       Impact factor: 8.807

Review 9.  Regulation of the Hippo pathway in cancer biology.

Authors:  Sungho Moon; So Yeon Park; Hyun Woo Park
Journal:  Cell Mol Life Sci       Date:  2018-03-30       Impact factor: 9.261

Review 10.  The Hippo Signaling Pathway in Development and Disease.

Authors:  Yonggang Zheng; Duojia Pan
Journal:  Dev Cell       Date:  2019-08-05       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.